Less Ads, More Data, More Tools Register for FREE

Edison

Edison's team of 50-plus analysts produces award-winning, tier one-standard equity research and investment analysis. In 2023, our international coverage includes daily in-depth scrutiny of over 225 stocks, connecting targeted investor groups across institutions, family offices, wealth managers and retail investors insight into our clients.

Edison specialises in expanding the global capital markets' understanding of our clients' investment cases. We do this through our unique combination of integrated services under the banner Complete IR which enhances our award-winning research with bespoke digital marketing services and investor relations engagement.
Date TIDM Title
24-Oct-24Datatec - Better profitability across the board
23-Oct-24GRIDGresham House Energy Storage Fund - Capacity augmentations the prio...
22-Oct-241NB.MINorthern Data Group - Flagship European provider of AI infrastructure
22-Oct-24UTLUIL - Working towards a 2028 privatisation
21-Oct-24OCNOcean Wilsons Holdings - Sale of Wilson Sons investment
21-Oct-24MFXManx Financial Group - Well prepared for potential headwinds
21-Oct-24DWLDowlais Group - Driveline - the strong core
21-Oct-240JYOBB Biotech - A key milestone with significance for the sector
21-Oct-24SPA1Spatial - £1m 1Streetworks deal highlights the opportunity
17-Oct-24PHPPrimary Health Properties - Highlighting organic and investment-led...
17-Oct-240RSLEsker - On track to meet FY24 guidance
16-Oct-24Alkane Resources - Seamlessly shifting to Roswell
16-Oct-24DSCVdiscoverIE Group - Orders stabilising, EPS & margin targets on track
15-Oct-24Actinogen Medical - A$11.1m capital raise completed
15-Oct-24Calgro M3 - Earnings underpinned by gross profit margin
15-Oct-24SUSS&U - The time to look ahead
14-Oct-24DIVIDiverse Income Trust (The) - Could be the time for UK equities to s...
14-Oct-24Altron - Strong earnings growth in H125
14-Oct-24JEDTJPMorgan European Discovery Trust - European small caps: On the ver...
14-Oct-24RGTArgent Biopharma - Valuation report
14-Oct-24SPA1Spatial - Contract momentum underpins growth prospects
11-Oct-240QNABasilea Pharmaceutica - Milestone march continues for Cresemba
11-Oct-24SARSareum Holdings - New funding extends runway to Phase II
11-Oct-24OCNOcean Wilsons Holdings - Confirmation of interest in Wilson Sons ho...
11-Oct-24IPOIP Group - Record exit underpinning the NAV
10-Oct-24CAUCentaur Media - Tough trading backdrop persists in H2
10-Oct-24USABaillie Gifford US Growth Trust - Seeking tomorrow’s mega caps
10-Oct-24MNY.USMoneyHero - Investing for the long term
09-Oct-24UTLUIL - Announcement of 2028 privatisation plans
09-Oct-24OSE.PAOSE Immunotherapeutics - Riding the H124 tailwinds